Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Minnesota extends Medicaid provider pause as fraud concerns reach U.S. Senate
Sonderling defends grant shift, vows fraud crackdown to senators
Advocate calls for stronger IDOC oversight after payroll fraud guilty plea
Illinois Quick Hits: FAFSA applications rise with increase in state taxpayer funding
Appeals court: Chicago’s ‘climate disinformation’ case belongs in Cook County
WATCH: Polish leader discusses Ukraine, Russia at Reagan Library
Firefighters from 30 states battle wildfires in Colorado
Democrats wary over DNI nominee’s stances on election security
GOP, Dems compete in Arizona congressional races
Abbott directs state investigation into ICE Houston shooting
Industry leaders: Feds can more effectively combat fraud, but privacy rights at risk
Union sues to stop $110B Paramount-Warner Bros. merger